Navigation Links
Pharmaceutical Direct to Consumer Advertising on The American Law Journal
Date:1/17/2010

PHILADELPHIA, Jan. 17 /PRNewswire/ -- In the last decade, the number of consumers taking antidepressants has more than doubled, with a staggering 4000% increase in the diagnosis of bipolar disorder in children in that time.  Doctors wrote 164 million prescriptions for antidepressants in 2008. Pharmaceutical companies spend billions of dollars on direct to consumer pharmaceutical advertising psychiatric drugs. Is there a connection? And when a patient experiences harm from a drug, does direct to consumer advertising play a role in litigation?

Monday January 18 live from 7:00-8:00 p.m. EST on the Philadelphia CNN-News affiliate WFMZ-TV and streaming online at WFMZ.com, The American Law Journal presents "Ask Your Doctor If 'x' is Right for You— Does Drug Advertising Help or Hurt the Consumer?" Philadelphia-based lawyers and a prominent pain physician address the legal, medical and social implications of direct to consumer drug advertising. Former New Jersey prosecutor Christopher Naughton, a legal commentator and 20-year legal broadcasting veteran, hosts the program.

On the panel representing consumers and pharmaceutical whistleblowers in nationwide, complex pharmaceutical litigation and recent landmark pharmaceutical settlements is Stephen Sheller, Esq. of the law firm of Sheller, P.C.. Raymond Williams, Esq. of DLA Piper brings his expertise defending top-tier pharmaceutical companies in high-profile cases to the conversation. Joining Sheller and Williams is physician Frank J.E. Falco, M.D., CEO of the Mid-Atlantic Spine & Pain Physicians
'/>"/>

SOURCE The American Law Journal
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015  The growing threat posed ... a sense of urgency to the development of ... R&D costs and provide incentives for new drug ... Logo - http://photos.prnewswire.com/prnh/20150331/195565LOGO ... Product and Pipeline Analysis of the Antibacterial Drugs ...
(Date:3/30/2015)... 31, 2015 The Allen Institute for ... to define and advance the state-of-the-art digital reconstruction ... today, called BigNeuron, aims to create reliable high-throughput ... branches that make up individual neurons: a crucial ... information. "In our quest to ...
(Date:3/30/2015)... and BRISBANE, Calif., March 30, 2015 Shareholder ... the proposed acquisition of Hyperion Therapeutics, Inc. (NASDAQ: ... HZNP ).  On March 30, 2015, the two companies ... to which Horizon will acquire Hyperion.  Under the terms ... cash for each share of Hyperion common stock. ...
Breaking Medicine Technology:Development and Commercialization of Antibacterial Drugs to Speed Up 2Development and Commercialization of Antibacterial Drugs to Speed Up 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 2International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 3International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 4International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 5International Initiative Launched to Advance State-of-the-Art Digital Tracings of Neurons 6Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 2Robbins Arroyo LLP: Acquisition of Hyperion Therapeutics, Inc. (HPTX) by Horizon Pharma plc (HZNP) May Not Be in Shareholders' Best Interests 3
... WESTMINSTER, Colo., Dec. 27 Allos,Therapeutics, Inc. (Nasdaq: ... Data,Monitoring Committee (DMC) has completed the pre-specified 65-patient,safety ... 2 PROPEL trial of,PDX (pralatrexate) in patients with ... recommended that the trial continue per the,protocol. This ...
... Traditional Approval -, YARDLEY, Pa., Dec. 21 ... Supplemental New Drug Application (sNDA) to the U.S. ... (PI) PREZISTA(TM),(darunavir) tablets, which seeks traditional approval and ... adults. The application includes 48-week data from two,Phase ...
Cached Medicine Technology:Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 2Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 3Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 4Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma 5Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 2Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 3Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 4Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration 5
(Date:3/31/2015)... Beckman Coulter is sponsoring a new educational webinar ... will highlight approaches used to extract more information from ... and will be broadcast live April 16, 2015 at ... for sedimentation data analysis have opened up ... range of technology sectors, including life science research, pharmaceutical ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The Denver ... District (RTD) are planning an array of public activities ... Signature Bus Tour and a Unity Parade and Rally ... for Transportation Day” – a national day of advocacy ... long-term, sustainable transportation funding. , The effort is being ...
(Date:3/31/2015)... An individual’s meniscus (cushion in the knee) ... leg providing stability, load bearing and preservation of the ... Day meeting of the American Orthopaedic Society for Sports ... the potential for biologic healing following a meniscus tear. ... of meniscus tears when a root repair is performed ...
(Date:3/31/2015)... March 31, 2015 The Oliver ... testosterone lawsuit claims, notes that filings for testosterone ... and other cardiovascular complications associated with testosterone therapy ... increasing at a steady pace. The website for ... where the testosterone lawsuits have been centralized, shows ...
(Date:3/31/2015)... March 31, 2015 The growing concern ... looking for options to protect themselves and their children. ... spring allergy season and recovering from an ugly flu ... relief to consumers – Aero One ( http://www.aero1UV.com ) ... only purges allergens from the air but also kills ...
Breaking Medicine News(10 mins):Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 2Health News:Beckman Coulter Webinar Series Presents Advances in Sedimentation Analysis 3Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 2Health News:DRCOG & RTD Invite The Public To Stand Up For Transportation Funding 3Health News:New Way to Evaluate Meniscus Tear Outcomes 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 2Health News:Testosterone Lawsuit Filings Rise To Over 1,200 In Multidistrict Litigation Pending In Northern Illinois Federal Court Reports The Oliver Law Group 3Health News:Startup Uses 3D-UV Technology to Take on Spring Allergies and Measles Virus 2Health News:Startup Uses 3D-UV Technology to Take on Spring Allergies and Measles Virus 3
... The deterioration of Hong Kong’s air quality has resulted in ... ,The deterioration of Hong Kong’s air quality ... with breathing problems. , , ,Researchers at ... such as sulphur dioxide, nitrogen dioxide and ozone of about ...
... The U.S. Food and Drug Administration (FDA) have approved a ... meats. This approval was given last month.// , ... Listeria. The approved spray is a combination of viruses that ... these foods before packaging and distribution. ,This virus ...
... A new study in the latest issue of the New ... help heart attack survivors. However more research is needed to ... effect of stem cells given to survivors of heart attacks ... hearts. Researchers looked at whether stem cells could repair the ...
... soothing guilt-free chocolate body wrap or deep relaxation with Indian ... a few years ago. ,But they are ... chattering classes, who seek a pampered lifestyle in the country's ... present to spend a few very feminine hours in one ...
... U.S. Food and Drug Administration on Wednesday reported having ... patch, cautioning users about the higher risk of blood ... Johnson’s commissioned study revealed that drug users faced two ... lungs compared to women taking traditional birth-control pills. ...
... experts, 80% of people suffering from severe chronic lung ... aware of it.// ,Chronic Bronchitis and Emphysema constitute ... to lung tissue by smoking can lead to the ... ,Professor Robert West, director of tobacco studies at ...
Cached Medicine News:Health News:Luxury Spas Ride Boom in Wellness Industry in Poland 2Health News:Contraceptive Patch Carries Risk of Blood clots 2Health News:80% of lung disease remains ‘undiagnosed’. 2
... Shoulder Immobilizer A chest binder ... with contact closure. Humerus strap ... wrist cuff. Plastic stay. 1 ... strap may adjust for hand ...
... of shoulder, elbow, wrist, and hand. Appliance ... supported by the opposite shoulder. Abduction can ... arm support attaches to pillow wedge at ... attached anywhere along length of arm. Humerus ...
The Humeral Stabilizing System is a terrific option for immobilization of stable humeral fractures, stablesupracondular fractures, and biceps/triceps repairs....
... Evans AFO is designed to treat or ... with immobility such as hip displasia, foot ... calcaneus. A comfortable Kodel lining provides a ... The anti-rotation bar is easily rotated and ...
Medicine Products: